FDA NDC Directory · JSON-LD · Markdown

ubrogepant

NDC 0074-6501 · DRUG FOR FURTHER PROCESSING · TABLET

Labeler / ManufacturerAbbVie Inc.
Marketing categoryDRUG FOR FURTHER PROCESSING
Dosage form / routeTABLET
Active ingredientsUBROGEPANT (100 mg/1)
Marketing started20260909
Package count1

External sources

Source: openFDA. Public-domain (CC0).